Los Angeles - The use of lipid-lowering drugs may inhibit the development of melanoma, according to results of two separate studies presented at the annual meeting of the Society for Investigative Dermatology.
Recent Povorcitinib 2b Study Shows Improved Repigmentation
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
POLL: What Topics Did You Most Enjoy at AAD 2023?
Lanolin Named Allergen of the Year
2 Clarke Drive Cranbury, NJ 08512